FilingSEC EDGAR8-K
Calidi Biotherapeutics Receives NYSE American Non-Compliance Notice
· SEC accepted
StageListing Deficiency
Filing content
The company received a notice of non-compliance with NYSE American listing standards due to stockholders' equity deficiency and must submit a compliance plan by October 21, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…